Monday, April 21, 2014

TearLab to acquire AOA’s OcuHub platform

TearLab to acquire AOA’s OcuHub platform

February 18, 2014 by · Leave a Comment 

Tweet TearLab (NASDAQ:TEAR; TSX:TLB) has signed a non-binding term sheet to purchase the assets of the OcuHub business unit from AOAExcel, the for-profit subsidiary of the American Optometric Association (“AOA”). OcuHub, powered by AT&T and Covisint, is an established compliant technology platform designed to securely connect eye doctors, patients, healthcare organizations and payers. The acquisition […]

TearLab issues prelim Q4 revenue and gives 2014 revenue guidance

TearLab issues prelim Q4 revenue and gives 2014 revenue guidance

February 3, 2014 by · Leave a Comment 

Tweet TearLab (NASDAQ:TEAR; TSX:TLB) said preliminary total revenue for the fourth quarter of 2013 is expected to be about $4.5-million, bringing expected full year 2013 revenue to about $14.7-million.   The preliminary expected revenue in the fourth quarter reflects an increase of about 181%, compared with revenue of $1.6-million in the fourth quarter of 2012. The […]

In conversation with Elias Vamvakas

In conversation with Elias Vamvakas

January 28, 2014 by · Leave a Comment 

Tweet As CEO of San Diego-based TearLab (NASDAQ:TEAR; TSX:TLB), eye care entrepreneur, Elias Vamvakas, has scored another home run with a medical device for the diagnosis and management of dry eye disease (DED). The TearLab Osmolarity System uses a novel lab-on-a-chip approach that requires less than 50 nanoliters of tear fluid in order to measure […]

TearLab included in Feltl’s 2014 Top Idea List

TearLab included in Feltl’s 2014 Top Idea List

January 2, 2014 by · Leave a Comment 

Tweet Feltl & Co. has released its 2014 Top Idea List, which included TearLab (NASDAQ:TEAR; TSX:TLB). Analyst Ben Haynor writes that TearLab has first-mover advantage in point-of-care diagnostics for dry eye disease (DED). The TearLab Osmolarity System is a lab-on-a-chip system that provides a quantitative measure (osmolarity) of DED in less than 30 seconds. He […]

AOA goes to bat for TearLab test with private insurers

AOA goes to bat for TearLab test with private insurers

December 20, 2013 by · Leave a Comment 

http://www.youtube.com/watch?v=p24huh7sOpI&feature=c4-overview-vl&list=PL8GkKmXDug1dWbk6nDUxsQBnR-jEi1vtr’]

Tweet The Third Party Center of the American Optometric Association has worked with several state payers to establish a favorable coverage and reimbursement policy for the diagnosis of dry eye disease using the TearLab (NASDAQ:TEAR; TSX:TLB) Osmolarity Test. In late October, the center contacted the medical director of BlueCross BlueShield of Western New York (BCBSWNY) and BlueShield […]

TearLab osmolarity test in UK DED prevalence study

TearLab osmolarity test in UK DED prevalence study

December 17, 2013 by · Leave a Comment 

Tweet In collaboration with the UK’s National Health Service (NHS), four ophthalmologists are beginning a 1,000-patient multi-center study to assess the overall prevalence of dry eye disease (DED), using the TearLab (NASDAQ:TEAR; TSX:TLB) Osmolarity Test for the diagnosis of DED. Patients who suffer from a wide variety of eye complications presenting daily in NHS clinics […]

TearLab added to the MSCI US Small Cap Index

TearLab added to the MSCI US Small Cap Index

November 25, 2013 by · Leave a Comment 

Tweet As a result of the November 2013 semi-annual index review for the MSCI equity indices, TearLab (NASDAQ:TEAR; TSX:TLB) will be deleted from the MSCI US Micro Cap Index and added to the MSCI US Small Cap Index after stock market close on November 26. A summary of stock deletions and additions to the MSCI equity indices can […]

TearLab Q3 revenue jumps 247%

TearLab Q3 revenue jumps 247%

November 12, 2013 by · Leave a Comment 

Tweet Net revenue for TearLab (NASDAQ:TEAR; TSX:TLB) rose 247% in the third quarter to $4.2-million from $1.2-million a year ago and was up 19% from $3.5-million in the second quarter this year. A total of 467 orders for TearLab Osmolarity systems were booked in the latest quarter.  That compares to 92 orders for TearLab systems […]

Alcon’s Seph Jensen joins TearLab as president & COO

Alcon’s Seph Jensen joins TearLab as president & COO

October 1, 2013 by · Leave a Comment 

Tweet TearLab (NASDAQ:TEAR; TSX:TLB) has named Seph Jensen as president and COO. He joins TearLab from his current position as head of surgical marketing at Alcon Laboratories, having responsibility for more than $1.4-billion in revenue across its cataract, retina and refractive businesses. “Seph is a seasoned leader with a strong track record of delivering operational […]

TearLab Q2 gets high marks from analysts

TearLab Q2 gets high marks from analysts

August 15, 2013 by · Leave a Comment 

Tweet TearLab (NASDAQ:TEAR; TSX:TLB) received widespread support from analysts after the company’s conference call on Tuesday evening, which included a panel discussion with four eye care professionals who use the TearLab Osmolarity System in their businesses. Feltl & Co. analyst Ben Haynor, who has raised his price target to $17 from $15 and reiterated his […]

Next Page »

Google+